Immune cell target that may prevent or delay heart failure after pressure overload

Researchers have identified a therapeutic target to prevent or delay heart failure from pressure overload of the heart, and a potential biomarker for the same. They say their animal studies carry clinical and translational potential. Mouse-model experiments showed that preventing the early infiltration of CCR2+ macrophages into the heart, after experimental pressure overload, significantly lessened the heart’s enlargement and reduced pumping ability that leads to later heart failure.

Go to Source

(Visited 3 times, 1 visits today)

Popular Posts